SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 288 filers reported holding SEATTLE GENETICS INC in Q1 2018. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $1,527,000 | +15.4% | 23,000 | -9.0% | 0.01% | +40.0% |
Q1 2018 | $1,323,000 | -10.9% | 25,280 | -8.9% | 0.01% | -28.6% |
Q4 2017 | $1,485,000 | +11.9% | 27,759 | +13.8% | 0.01% | 0.0% |
Q3 2017 | $1,327,000 | +15.0% | 24,385 | +9.3% | 0.01% | 0.0% |
Q2 2017 | $1,154,000 | -40.5% | 22,318 | -37.8% | 0.01% | -53.3% |
Q3 2016 | $1,938,000 | +5.9% | 35,900 | -20.8% | 0.02% | +7.1% |
Q2 2016 | $1,830,000 | -11.1% | 45,300 | -22.8% | 0.01% | -17.6% |
Q1 2016 | $2,059,000 | -64.2% | 58,700 | -54.2% | 0.02% | -10.5% |
Q4 2015 | $5,754,000 | +0.5% | 128,200 | -13.7% | 0.02% | -36.7% |
Q3 2015 | $5,726,000 | -43.8% | 148,500 | -29.4% | 0.03% | -50.0% |
Q2 2015 | $10,184,000 | +222.6% | 210,400 | +135.6% | 0.06% | +150.0% |
Q1 2015 | $3,157,000 | +427.9% | 89,300 | +379.9% | 0.02% | +500.0% |
Q4 2014 | $598,000 | +122.3% | 18,608 | +215.4% | 0.00% | +100.0% |
Q1 2014 | $269,000 | -14.6% | 5,900 | -41.0% | 0.00% | +100.0% |
Q2 2013 | $315,000 | – | 10,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 45,725,556 | $2,487,928,000 | 20.18% |
Lagoda Investment Management, L.P. | 306,694 | $16,687,000 | 6.03% |
NEXTHERA CAPITAL LP | 373,000 | $20,295,000 | 5.22% |
Redmile Group, LLC | 1,843,733 | $100,318,000 | 4.95% |
Matrix Capital Management Company, LP | 2,118,000 | $115,240,000 | 3.68% |
Sio Capital Management, LLC | 100,000 | $5,441,000 | 2.82% |
Opus Point Partners Management, LLC | 41,263 | $2,245,000 | 2.01% |
Eventide Asset Management | 525,000 | $28,565,000 | 1.62% |
EMORY UNIVERSITY | 35,982 | $1,958,000 | 1.55% |
Everett Capital Advisors UK LLP | 191,500 | $10,420,000 | 1.54% |